B K H Law1, A D King2, K S Bhatia1, A T Ahuja1, M K M Kam3, B B Ma3, Q Y Ai1, F K F Mo3, J Yuan4, D K W Yeung3. 1. From the Departments of Imaging and Interventional Radiology (B.K.H.L., A.D.K., K.S.B., A.T.A., Q.Y.A.). 2. From the Departments of Imaging and Interventional Radiology (B.K.H.L., A.D.K., K.S.B., A.T.A., Q.Y.A.) king2015@cuhk.edu.hk. 3. Clinical Oncology (M.K.M.K., B.B.M., F.K.F.M., D.K.W.Y.), The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong S.A.R., China. 4. Medical Physics and Research Department (J.Y.), Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong S.A.R., China.
Abstract
BACKGROUND AND PURPOSE: Pretreatment prediction of patients with nasopharyngeal carcinoma who will fail conventional treatment would potentially allow these patients to undergo more intensive treatment or closer posttreatment monitoring. The aim of the study was to determine the ability of pretreatment DWI to predict local failure in patients with nasopharyngeal carcinoma based on long-term clinical outcome. MATERIALS AND METHODS: One hundred fifty-eight patients with pretreatment DWI underwent analysis of the primary tumor to obtain the ADC mean, ADC skewness, ADC kurtosis, volume, and T-stage. Univariate and multivariate analyses using logistic regression were performed to compare the ADC parameters, volume, T-stage, and patient age in primary tumors with local failure and those with local control, by using a minimum of 5-year follow-up to confirm local control. RESULTS: Local control was achieved in 131/158 (83%) patients (range, 60.3-117.7 months) and local failure occurred in 27/158 (17%) patients (range, 5.2-79.8 months). Compared with tumors with local control, those with local failure showed a significantly lower ADC skewness (ADC values with the greatest frequencies were shifted away from the lower ADC range) (P = .006) and lower ADC kurtosis (curve peak broader) (P = .024). The ADC skewness remained significant on multivariate analysis (P = .044). There was a trend toward higher tumor volumes in local failure, but the volume, together with T-stage and ADC mean, were not significantly different between the 2 groups. CONCLUSIONS: Pretreatment DWI of primary tumors found that the skewness of the ADC distribution curve was a predictor of local failure in patients with nasopharyngeal carcinoma, based on long-term clinical outcome.
BACKGROUND AND PURPOSE: Pretreatment prediction of patients with nasopharyngeal carcinoma who will fail conventional treatment would potentially allow these patients to undergo more intensive treatment or closer posttreatment monitoring. The aim of the study was to determine the ability of pretreatment DWI to predict local failure in patients with nasopharyngeal carcinoma based on long-term clinical outcome. MATERIALS AND METHODS: One hundred fifty-eight patients with pretreatment DWI underwent analysis of the primary tumor to obtain the ADC mean, ADC skewness, ADC kurtosis, volume, and T-stage. Univariate and multivariate analyses using logistic regression were performed to compare the ADC parameters, volume, T-stage, and patient age in primary tumors with local failure and those with local control, by using a minimum of 5-year follow-up to confirm local control. RESULTS: Local control was achieved in 131/158 (83%) patients (range, 60.3-117.7 months) and local failure occurred in 27/158 (17%) patients (range, 5.2-79.8 months). Compared with tumors with local control, those with local failure showed a significantly lower ADC skewness (ADC values with the greatest frequencies were shifted away from the lower ADC range) (P = .006) and lower ADC kurtosis (curve peak broader) (P = .024). The ADC skewness remained significant on multivariate analysis (P = .044). There was a trend toward higher tumor volumes in local failure, but the volume, together with T-stage and ADC mean, were not significantly different between the 2 groups. CONCLUSIONS: Pretreatment DWI of primary tumors found that the skewness of the ADC distribution curve was a predictor of local failure in patients with nasopharyngeal carcinoma, based on long-term clinical outcome.
Authors: Vincent Lai; Xiao Li; Victor Ho Fun Lee; Ka On Lam; Daniel Yee Tak Fong; Bingsheng Huang; Queenie Chan; Pek Lan Khong Journal: Eur Radiol Date: 2013-08-29 Impact factor: 5.315
Authors: Maarten Lambrecht; Ben Van Calster; Vincent Vandecaveye; Frederik De Keyzer; Ilse Roebben; Robert Hermans; Sandra Nuyts Journal: Radiother Oncol Date: 2014-03-11 Impact factor: 6.280
Authors: D T Chua; J S Sham; D L Kwong; K S Tai; P M Wu; M Lo; A Yung; D Choy; L Leong Journal: Int J Radiat Oncol Biol Phys Date: 1997-10-01 Impact factor: 7.038
Authors: Edmund A Mroz; Aaron D Tward; Curtis R Pickering; Jeffrey N Myers; Robert L Ferris; James W Rocco Journal: Cancer Date: 2013-05-20 Impact factor: 6.860
Authors: Stavroula Kyriazi; David J Collins; Christina Messiou; Kjell Pennert; Robert L Davidson; Sharon L Giles; Stan B Kaye; Nandita M Desouza Journal: Radiology Date: 2011-08-09 Impact factor: 11.105
Authors: Qi-Yong Ai; Ann D King; Benjamin King Hong Law; David Ka-Wai Yeung; Kunwar S Bhatia; Jing Yuan; Anil T Ahuja; Lok Yiu Sheila Wong; Brigette B Ma; Frankie Kwok Fai Mo; Michael K M Kam Journal: Eur Arch Otorhinolaryngol Date: 2016-10-08 Impact factor: 2.503